Elaine H. Elder

Suggest Changes

Writes About:

Learn More
We designed a phase I clinical trial of vaccinations with autologous glioma cells expressing transgene-derived interleukin-4 (IL-4), and treated one patient with a right temporal lobe recurrent(More)